Pharmaceutical Launch Sequencing Trends: Designing Each Product Launch Sequence From Scratch
05 juil. 2017 18h53 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 05, 2017) - About 81% of surveyed Top 10, Top 50, and small pharmaceutical and medical device firms build launch sequences from scratch for each...
Brazil, Russia, India, and China (BRIC) Becoming Popular Second Wave Targets, Recent Study Finds
10 mai 2017 15h30 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - May 10, 2017) - Emerging markets such as Brazil and India are becoming common second wave targets for pharmaceutical product launches, according to a recent...
Pharmaceutical Companies Targeting Major Western Markets for New Drug Launches
14 sept. 2016 08h08 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 14, 2016) - A recent study found that 74% of surveyed drug companies market new products in the US during their first launch wave. During this same...
Pharma Launch Sequencing Trends: Brand Team Involvement in Ad Hoc Committees
24 août 2016 07h41 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 24, 2016) - Although pharmaceutical brand teams do not have the final say on their products' launch sequences, they play an active role in ad hoc...
Study Finds 88% of Pharma Companies Base Global Launch Planning on Regulatory Affairs Guidance
20 juil. 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 20, 2016) - A new benchmarking study published by Cutting Edge Information discovered that regulatory guidance is the most common tool that...
62% of Surveyed Pharma Companies Look to C-Suite for Final Sequencing Decisions
13 juil. 2016 08h38 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 13, 2016) - Within pharmaceutical organizations, the ultimate responsibility for approving launch sequences among 62% of companies lies with C-level...
77% of Surveyed Pharma Companies Use Ad Hoc Launch Sequencing Committees Instead of Dedicated Teams
30 juin 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 30, 2016) - While executing a new drug launch, 77% of surveyed pharmaceutical companies look to ad hoc launch sequencing groups rather than maintaining...
62% of C-Level Executives Dominate the Approval of Pharmaceutical Launch Sequences
17 juin 2016 08h38 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 17, 2016) - A new study published by Cutting Edge Information found that 50% of Top 10 and Top 50 firms turn to C-level executives when planning launch...